ExodusPoint Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
ExodusPoint Capital Management's RMD Position: Q4 2025 in Review
ExodusPoint Capital Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 8,706 shares — an estimated $2.38M sold.
ExodusPoint Capital Management first reported a position in RMD in Q3 2019 and held it in 14 quarters. The position peaked at $18.6M in Q2 2023. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.
- ExodusPoint Capital Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
- ExodusPoint Capital Management sold 8,706 ResMed shares in Q4 2025, an estimated $2.38M.
- ExodusPoint Capital Management first reported a position in ResMed in Q3 2019 and held it in 14 quarters.
- ExodusPoint Capital Management's ResMed position peaked at $18.6M in Q2 2023.
- 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.
Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.